Bionomics Limited (NASDAQ: BNOX)
$0.74
-0.0249 ( -3.25% ) 17.0K
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
Market Data
Open
$0.74
Previous close
$0.77
Volume
17.0K
Market cap
$10.07M
Day range
$0.75 - $0.78
52 week range
$0.65 - $6.41
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
20-f/a | Annual reports | 12 | Jan 17, 2024 |
6-k | Quarterly Reports | 1 | Jan 04, 2024 |
6-k | Quarterly Reports | 3 | Nov 30, 2023 |
6-k | Quarterly Reports | 3 | Nov 28, 2023 |
6-k | Quarterly Reports | 4 | Nov 03, 2023 |
20-f | Annual reports | 182 | Oct 18, 2023 |
6-k | Quarterly Reports | 3 | Oct 16, 2023 |
6-k | Quarterly Reports | 10 | Sep 29, 2023 |
6-k | Quarterly Reports | 4 | Sep 28, 2023 |
6-k | Quarterly Reports | 3 | Jul 31, 2023 |